IL42232A - Dry medicines for oral administration - Google Patents

Dry medicines for oral administration

Info

Publication number
IL42232A
IL42232A IL42232A IL4223273A IL42232A IL 42232 A IL42232 A IL 42232A IL 42232 A IL42232 A IL 42232A IL 4223273 A IL4223273 A IL 4223273A IL 42232 A IL42232 A IL 42232A
Authority
IL
Israel
Prior art keywords
active principle
binder
physiologically inert
process according
active
Prior art date
Application number
IL42232A
Other languages
English (en)
Other versions
IL42232A0 (en
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of IL42232A0 publication Critical patent/IL42232A0/xx
Publication of IL42232A publication Critical patent/IL42232A/en
Priority to IL7752864A priority Critical patent/IL52864A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
IL42232A 1972-05-10 1973-05-09 Dry medicines for oral administration IL42232A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL7752864A IL52864A (en) 1973-05-09 1977-08-31 Process for producing oral pharmaceutical compositions having delayed action

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7216616A FR2183546B1 (ko) 1972-05-10 1972-05-10

Publications (2)

Publication Number Publication Date
IL42232A0 IL42232A0 (en) 1973-07-30
IL42232A true IL42232A (en) 1976-08-31

Family

ID=9098254

Family Applications (1)

Application Number Title Priority Date Filing Date
IL42232A IL42232A (en) 1972-05-10 1973-05-09 Dry medicines for oral administration

Country Status (17)

Country Link
US (1) US3950508A (ko)
JP (1) JPS5526124B2 (ko)
AR (1) AR203268A1 (ko)
BE (1) BE799331A (ko)
CA (1) CA1041906A (ko)
DD (1) DD104027A5 (ko)
DE (1) DE2323686A1 (ko)
DK (1) DK137706B (ko)
FI (1) FI56623C (ko)
FR (1) FR2183546B1 (ko)
GB (1) GB1421964A (ko)
HU (1) HU168307B (ko)
IL (1) IL42232A (ko)
IN (1) IN139518B (ko)
NL (1) NL158388B (ko)
OA (1) OA04380A (ko)
ZA (1) ZA733188B (ko)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923939A (en) * 1974-06-07 1975-12-02 Alza Corp Process for improving release kinetics of a monolithic drug delivery device
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4985017A (en) * 1981-07-13 1991-01-15 Alza Corporation Parenteral therapeutical system comprising drug cell
EP0094116A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
BR8406921A (pt) * 1983-05-31 1985-06-04 Choong Gook Jang Composicoes secas de compressao,direta para formas de dosagem de liberacao controlada
JPS60104804A (ja) * 1983-11-09 1985-06-10 Nippon Ferrite Ltd エア抜き装置
JPS60104805A (ja) * 1983-11-09 1985-06-10 Nippon Ferrite Ltd エア抜き装置
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
GB2257363B (en) * 1991-01-30 1994-09-28 Wellcome Found Water dispersible tablets containing acyclovir
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
DE69332801T2 (de) * 1992-11-30 2004-01-29 Kv Pharm Co Geschmacksmaskierte pharmazeutische substanzen
IL119660A (en) * 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
FR2760190B1 (fr) * 1997-02-28 1999-04-09 Adir Composition pharmaceutique pour la liberation programmee de dexfenfluramine
IN186245B (ko) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
TR200001942T2 (tr) 1997-12-22 2000-11-21 Euro-Celtique, S.A. Opioid agonist/antagonist kombinasyonlar
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
AUPQ573300A0 (en) 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
WO2002092060A1 (en) 2001-05-11 2002-11-21 Endo Pharmaceuticals, Inc. Abuse-resistant controlled-release opioid dosage form
PT2425824T (pt) 2002-04-05 2017-08-23 Mundipharma Farmacêutica Lda Preparação farmacêutica contendo oxicodona e naloxona
US20050019397A1 (en) * 2003-07-23 2005-01-27 Jacobs Richard L. Cellulosic fiber containing composition
BRPI0509148B8 (pt) * 2004-03-22 2021-05-25 Abbott Products Gmbh composições farmacêuticas orais de produtos contendo lipase, em particular de pancreatina contendo tensoativos, seus usos e respectivos processos de fabricação
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP2319499A1 (en) * 2005-01-28 2011-05-11 Euro-Celtique S.A. Alcohol resistant dosage forms
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
HUE034739T2 (en) * 2005-07-29 2018-02-28 Abbott Laboratories Gmbh Reduced viral pancreatin
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
EP2317991B1 (en) * 2008-07-07 2017-05-03 Euro-Celtique S.A. Use of opioid antagonists for treating urinary retention
JP5886632B2 (ja) 2009-03-10 2016-03-16 ユーロ−セルティーク エス．エイ． オキシコドンおよびナロキソンを含む即時放出医薬組成物
WO2015011189A1 (en) 2013-07-23 2015-01-29 Euro-Celtique S.A. A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993836A (en) * 1958-02-20 1961-07-25 Dow Chemical Co Sustained release tablets
US2980589A (en) * 1958-09-12 1961-04-18 American Cyanamid Co Process for producing anhydrous granulation of a medicinally active waterlabile powder
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
FR1473805A (fr) * 1959-10-01 1967-03-24 Merck & Co Inc Véhicule pharmaceutique
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
US3453360A (en) * 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3507952A (en) * 1968-12-20 1970-04-21 Smithkline Corp Sustained release bolus for animal husbandry
GB1359643A (en) * 1970-09-28 1974-07-10 Controlled Medications Controlled release medicament
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3773921A (en) * 1971-11-15 1973-11-20 Hoffmann La Roche Therapeutic compositions

Also Published As

Publication number Publication date
CA1041906A (fr) 1978-11-07
AU5531473A (en) 1974-11-07
HU168307B (ko) 1976-03-28
GB1421964A (en) 1976-01-21
NL158388B (nl) 1978-11-15
FR2183546B1 (ko) 1975-06-20
US3950508A (en) 1976-04-13
ZA733188B (en) 1975-01-29
DK137706B (da) 1978-04-24
FI56623B (fi) 1979-11-30
IL42232A0 (en) 1973-07-30
NL7306422A (ko) 1973-11-13
AR203268A1 (es) 1975-08-29
DD104027A5 (ko) 1974-02-20
FR2183546A1 (ko) 1973-12-21
DE2323686A1 (de) 1973-11-22
BE799331A (fr) 1973-11-09
IN139518B (ko) 1976-06-26
DK137706C (ko) 1982-11-15
FI56623C (fi) 1980-03-10
OA04380A (fr) 1980-02-15
JPS4992217A (ko) 1974-09-03
JPS5526124B2 (ko) 1980-07-11

Similar Documents

Publication Publication Date Title
IL42232A (en) Dry medicines for oral administration
US4842866A (en) Slow release solid preparation
US3773920A (en) Sustained release medicinal composition
CA1240925A (en) Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
FI100219B (fi) Menetelmä farmaseuttisen granulaatin valmistamiseksi
GB1471564A (en) Direct compression tabletting composition and tablets produced therefrom
KR840005661A (ko) 지속성 매트릭스 정제 조성물의 제조방법
GB1359643A (en) Controlled release medicament
KR850000975A (ko) 발프로익산과 그 염의 혼합물을 토대로 한 조성물
ES403435A1 (es) Metodo para la preparacion de una composicion farmaceutica de liberacion lenta.
KR890001526A (ko) 경구용 서방성 아세트 아미노펜 제형 및 이의 제조방법
HU900638D0 (en) Process for preparing modified gembifrozil preparations with retard release
MY104010A (en) Pharmaceutical compositions.
US3632778A (en) Tablets containing l-dopa
US4143129A (en) Cephalexin tablets
US3679794A (en) Process for the manufacture of rapidly disintegrating solid dosage unit forms
US20110142944A1 (en) Andrographis extract formulations
DK163172B (da) Fremgangsmaade til fremstilling af ascorbinsyregranulat indeholdende pvp
JPS6320409B2 (ko)
KR880004801A (ko) 서방성 약학적 조성물
GB1506345A (en) Multitioned tablets
US7326427B2 (en) Tablet composition containing Kampo medicinal extract and its manufacturing process
RU2124899C1 (ru) Способ получения противоязвенного средства
JP4122544B2 (ja) 錠剤組成物
KR100358614B1 (ko) 푸시드산정제의제조방법